ARCHIVES

NCI Criticized For Delays In Development Of New Drugs

This article is from The Cancer Letter archive.

Vol. 01 No. 04 | January 24, 1975

Download PDF Visit The Full Archive

Related Articles

FCRF Recompetition Intriguing, Involved Various Possibility

May 9, 1986

High Response Rate of Hairy Cell Leukemia Patients to Immunotoxin Treatment In Phase I

April 27, 2001

FDA Issues Final Regs for Mammography Facilities, Personnel

November 7, 1997

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

R. Lee Clark, 87, M.D. Anderson Mastermind, dies

May 13, 1994

In Legal Brawl, UPenn and Abramson Institute Allege Former Director Craig Thompson “Absconded” With Inventions

March 9, 2012